SciSparc

Groundbreaking Therapies

Tel Aviv, Israel · Founded 2004

Headquarters
Tel Aviv
Founded
2004
Business Model
B2B

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

SciSparc develops proprietary compounds targeting receptors involved in regulating the central nervous system to mitigate symptoms of CNS disorders. Its primary platforms focus on the endocannabinoid system. Its pipeline combines approved compounds and new chemical entities intended for conditions without existing or sufficiently effective therapies.

Summary

SciSparc is a Biotech company based in Tel Aviv, Israel, founded in 2004.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Company Event History

Secondary MarketSecondary MarketNov 2025

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SciSparc on Indexed.vc
<a href="https://indexed.vc/companies/scisparc"><img src="https://indexed.vc/api/badge/company/scisparc" alt="SciSparc on Indexed.vc" width="260" height="76" /></a>